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OBJECTIVE — Peripheral arterial disease (PAD) is a prognostic marker in cardiovascular
disease. The use of Doppler-measured ankle-brachial pressure index (Dop-ABI) for PAD diag-
nosis is limited because of time, required training, and costs. We assessed automated oscillo-
metric measurement of the ankle-brachial pressure index (Osc-ABI) by nurses and clinical staff.
RESEARCH DESIGN AND METHODS — Clinical staff obtained Osc-ABI with an
automated oscillometric device in 146 patients (83 with diabetes) at the time of Dop-ABI
measurement and ultrasound evaluation.
RESULTS — Measurements were obtained in most legs (Dop-ABI 98%; Osc-ABI 95.5%).
Dop- and Osc-ABI were signiﬁcantly related in diabetic and nondiabetic patients with good
agreementoverawiderangeofvalues.WhenDop-ABI0.90wasusedasthegoldstandardforPAD,
receiver operating characteristic curve analysis showed that PAD was accurately diagnosed with
Osc-ABI in diabetic patients. When ultrasound was used to deﬁne PAD, Dop-ABI had better diag-
nosticperformancethanOsc-ABIinthewholepopulationandindiabeticpatients(P0.026).Both
methods gave similar results in nondiabetic patients. The cutoff values for the highest sensitivity and
speciﬁcity for PAD screening were between 1.0 and 1.1. Estimation of cost with the French medical
care system fees showed a potential reduction by three of the screening procedures.
CONCLUSIONS — PAD screening could be improved by using Osc-ABI measured by clin-
ical staff with the beneﬁt of greater cost-effectiveness but at the risk of lower diagnostic perfor-
mance in diabetic patients.
Diabetes Care 32:1231–1236, 2009
P
eripheral arterial disease (PAD) is a
frequent manifestation of athero-
sclerosis in the general population
andistwotofourtimesmoreprevalentin
diabetic patients (1). A continuous wave
Doppler-measured ankle-brachial pres-
sure index (Dop-ABI) 0.90 is commonly
used for diagnosing PAD (2,3). Ankle-
brachial pressure index (ABI) sensitivity is
79% and speciﬁcity is 96% for detection of
50% reduction in vascular lumina (4).
Moreover, Dop-ABI has prognostic value
for cardiovascular morbidity and mortality
and for coronary heart disease in particular
(5).DespitetheapparentsimplicityofDop-
ABI measurements, they are time consum-
ing and require technical skill and a
dedicated device (2,6,7), which preclude
routineuseofABImeasurementsingeneral
practice (6). PAD remains largely underdi-
agnosed(1),particularlyindiabeticpatients
in whom it is frequently associated with
lower limb complications (8).
Automated oscillometric determina-
tion of blood pressure is commonly used
for screening for hypertension (9). De-
vices are widely available and reliable
(9,10). Several studies reported auto-
mated oscillometric ankle-brachial pres-
sure index measurement (Osc-ABI) with
good agreement with Dop-ABI results
(11,12), suggesting that it might be used
for PAD screening.
In this study, we evaluated Osc-ABI
and Dop-ABI for PAD screening with ul-
trasound as a reference diagnostic proce-
dureindiabeticandnondiabeticpatients.
Furthermore, we assessed the possible
utility of involving nurses and clinical
staff in PAD screening.
RESEARCH DESIGN AND
METHODS— A total of 146 consecu-
tive patients (292 lower limbs), referred
tothephysiologydepartmentforDoppler
ultrasound evaluation of PAD, were pro-
spectively included in the study. A sub-
group of 83 patients had known diabetes
(56.8%). Risk factors were self reported
by the patient, and biological values were
found in medical ﬁles. The lower limbs
were classiﬁed as clinically normal when
skin was normal and both dorsalis pedis
and posterior tibialis pulses were present.
The subjects gave informed consent to
participate in the study.
Ultrasound examination
Doppler measurement and two-
dimensional ultrasound examination
were conducted by a single investigator
(C.C.), using the Toshiba Powervision
7000 10-MHz linear probe. Two-
dimensional images and Doppler interro-
gation were obtained for iliac to ankle
arteriesandtheabdominalaorta.Stenoses
were evaluated with the ratio of the max-
imalsystolicvelocityatstenosistothesys-
tolic velocity proximal to the stenosis.
Arteries were classiﬁed as having no sig-
niﬁcant stenosis when velocity ratios
were 2.
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ABI was measured in all patients at the
time of Doppler ultrasound examination.
Osc-ABIwasmeasuredwithanautomatic
device (Dynamap 8100, Critikon, Little
Chalfont, Buckinghamshire, U.K.) by
nurses or clinical staff. Systolic blood
pressure was measured with the cuff
placed above the ankles for both legs and
both arms. Nurses or clinical staff were
taught to measure Osc-ABI, i.e., to install
the cuff with the sampling area facing the
ankle artery, namely posterior, and ante-
rior tibial artery for ankle measurement
and brachial artery. This instruction was
achievedinasingletrainingsession.Dop-
ABI was measured by a single investigator
(C.C.) with a continuous wave Doppler
device (MD2, 8-MHz probe, Huntleigh,
Luton, U.K.). Measurement was obtained
at the posterior and anterior tibial arteries
and both brachial arteries. ABI was com-
puted as the ratio of ankle blood pressure
tothehighestbrachialsystolicbloodpres-
sure for both Osc-ABI and Dop-ABI.
Evaluation of costs
Costs of procedures were derived from
the French medical care system fees for
Doppler ultrasound examination or ABI
measurement, combined with a visit with
a cardiologist, a general practitioner, or a
nurse.
Statistical analysis
The data were analyzed with SAS software
(version9.1;SASInstitute).Qualitativeand
quantitative variables were compared using

2 and Student’s t tests, respectively. The
level of agreement between Osc-ABI and
Dop-ABI was assessed both by correlation
analysis using Pearson’s correlation coefﬁ-
cient and by a Bland-Altman plot (13). Re-
ceiver operating characteristic (ROC)
curves were computed as well as areas un-
der ROC curves using PROC LOGISTIC;
curve areas were compared using a non-
parametric approach (14) implemented in
an SAS macro for correlated data or a Wald
test (15).
Positive predictive value (PPV) and
negative predictive value (NPV) were
computed. The positive likelihood ratio
was computed as the probability of true
positive over the probability of false pos-
itive,andthenegativelikelihoodratiowas
computed as the probability of false neg-
ative over the probability of true negative.
The MacNemar test was used to compare
sensitivity and speciﬁcity. P  0.05 was
considered as signiﬁcant. Data are shown
as means  SD.
RESULTS— Population characteristics
for diabetic and nondiabetic patients are
showninTable1.Diabeticpatientshadmi-
crovascular disease with nephropathy
(34.6%),retinopathy(35.8%),andneurop-
athy (48.1%) or macrovascular disease
(40.7%) including coronary artery disease,
PAD, stroke, or carotid stenosis. PAD was
clinically suspected because of the absence
ofdistalarterypulsesin54%ofnondiabetic
patients and 40% of diabetic patients. PAD
was diagnosed with Dop-ABI in 33% of
nondiabetic patients and 27% of diabetic
patients. Doppler ultrasound examination
showed at least one arterial stenosis in
41.7%ofthelegsindiabeticpatientsandin
50.8% of the legs in nondiabetic patients. A
proximal localization (i.e., iliac or femoral
artery) was more frequent in nondiabetic
than in diabetic patients (37.7 and 5.2% of
thelocalizations,respectively,P0.0001),
who had more distal localization (72.0 vs.
20.8% of the localizations in nondiabetic
patients, P  0.0004).
Both techniques of ABI measurement
were highly correlated
Dop-ABI was measurable in 98% of the
total population studied (97% of diabetic
and 99.2% of nondiabetic patients),
whereas Osc-ABI was obtained in 95.5%
Table 1—Population characteristics
No diabetes Diabetes P
n 63 83
Sex (% male) 65 71
Age (years) 61.3  18.1 (19–92) 62.5  10.9 (35–91) 0.62
BMI (kg/m²) 25.1  5.1 (16–42) 28.6  5.6 (17.3–44.9)* 0.002
Overweight (BMI 25) 33 (50.8%) 58 (71.6%)* 0.03
Obesity (BMI 30) 12 (18.5%) 33 (40.7%)* 0.007
Systolic blood pressure (mmHg) 138.5  20.3 (78–211) 147  22.9 (103–197)* 0.02
Diastolic blood pressure (mmHg) 73.2  12.3 (39–100) 76.3  15.3 (48–139) 0.20
Pulse pressure (mmHg) 65.2  15.2 (39–112) 70.5  15.5 (43–105)* 0.04
Normal clinical limb examination 29 (46) 50 (60.2) 0.11
Dyslipidemia 22 (34.9) 37 (44.6)* 0.01
Hypertension 29 (46) 63 (75.9)* 0.0002
Smoking 28 (44.4) 22 (26.5)* 0.03
Coronary artery disease 20 (31.7) 22 (26.5) 0.58
Stroke 6 (9.5) 5 (6) 0.63
Clinical peripheral artery disease 9 (14.3) 25 (30.1)* 0.0016
Family history of cardiovascular disease 8 (12.7) 6 (7.2) 0.25
Diabetes duration (years) — 11.7  10.9 (0.5–57)
A1C (%) NA 8.44  2.06 (5–13.7)
Total cholesterol (mg/dl) 196  39 (124–260) 183  42 (50–206) 0.32
LDL cholesterol (mg/dl) 117  33 (67–184) 104  37 (50–206) 0.19
HDL cholesterol (mg/dl) 52  15 (24–76) 49  14 (25–83) 0.48
Triglycerides (mg/dl) 136  56 (56–255) 146  74 (29–377) 0.37
Creatinine (M) 120  93 (50–470) 109  63 (56–450) 0.50
Data are means  SD (range) or n (%). *P  0.05 with t test comparison of means or 
2 test comparison of frequencies.
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0.16 for comparison of techniques), in
95.8% of diabetic patients, and in 95.3%
of nondiabetic patients. When Osc-ABI
was not measurable, Dop-ABI was either
notmeasurableor0.90inmostpatients
(9 of 13 legs).
Osc-ABI was related to Dop-ABI (r 
0.53,P0.0001)inthetotalpopulation,
as well as in nondiabetic patients and in
diabetic patients (Fig. 1A). Bland-Altman
representation showed that Dop-ABI and
Osc-ABI were in good agreement in a
wide range of values, and the difference
did not vary with the average values in
any signiﬁcant way (Fig. 1B). The mean
difference between the two methods was
0.0207  0.27 in the total population,
0.028  0.25 in diabetic patients, and
0.0098  0.28 in nondiabetic patients.
Osc-ABI performance for diagnosis
of PAD, as deﬁned by Dop-ABI
<0.90
ROCcurvesconstructedforOsc-ABIwith
Dop-ABI 0.90 deﬁning PAD (Fig. 2A)
showed a high diagnostic accuracy. Areas
under the curve (AUCs) of ROC curves
were not different in diabetic and nondi-
abetic patients (AUC 0.83 and 0.844, re-
spectively, P  0.66). The best cutoff
value for optimal sensitivity and speciﬁc-
ity was 1.02 in the whole population,
1.04 in diabetic patients, and 1.0 in non-
diabetic patients (Fig. 2B).
Osc-ABI and Dop-ABI performance
for diagnosis of peripheral artery
stenosis
ROC curves were constructed for Dop-
ABI and Osc-ABI with stenosis at ultra-
sound as the criterion for diagnosis of
PAD (Fig. 3A). The ROC curve analyses
showed that Dop-ABI was better than
Osc-ABI for correctly classifying patients
for PAD (AUCDop-ABI 0.873, AUCOsc-ABI
0.806,P0.026).Dop-ABIperformance
was equivalent in nondiabetic and dia-
betic patients (P  0.068 for AUCs of
ROC curves), whereas Osc-ABI did not
perform as well as Dop-ABI in diabetic
patients (P  0.026 for ROC AUC
comparison).
The diagnostic accuracy for selected
ABI thresholds (Table 2) showed that the
commonly used value of 0.90 has a high
speciﬁcity but a medium sensitivity in the
wholepopulation.ThesensitivityofDop-
ABI and Osc-ABI was greater in the non-
diabetic population compared with that
in diabetic patients. Thus, a threshold
valueof0.90deﬁnedahighlyspeciﬁctest
at the expense of sensitivity for both Dop-
ABI and Osc-ABI. Dop-ABI and Osc-ABI
presented high PPVs in the total popula-
tion (95.3 and 88.1%, respectively) but
also in diabetic patients (92.5 and 83.3%,
respectively).Conversely,NPVswereme-
dium in both the whole population (76.1
and 65.9%, respectively) and diabetic pa-
tients (74.7 and 66.2%, respectively). To
optimize the threshold values of ABI for
screening and diagnosis, respectively,
ROCcurveswerefurtheranalyzed.Figure
3B and C shows that the highest sensitiv-
ity and speciﬁcity were achieved at cutoff
values between 1 and 1.1 for both Dop-
ABIandOsc-ABIinpatientswithorwith-
out diabetes.
Evaluation of costs of the screening
procedure
AccordingtotheFrenchmedicalcaresys-
tem, the costs of PAD screening would be
121€ (162 US dollars [USD]) with a vas-
cular ultrasound study only or 66€ (88
USD)withABIonlybyacardiologist,43€
(58USD)withABIonlybyageneralprac-
titioner, and 33€ (44 USD) with ABI only
by a nurse.
Figure 1—Relationship between Dop-ABI and Osc-ABI in nondiabetic (A)( r  0.60; P
 0.0001)anddiabetic(B)(r  0.49;P  0.0001)patients.C:Bland-Altmanrepresentation
of Doppler and oscillometric measurement of ABI in the whole population and the 95% limit
of agreement to the mean difference.
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cillometric ABI measurement by clinical
assistants with little formal training was
shown to be feasible in most patients, in-
cluding diabetic patients. The diagnostic
efﬁciency was close to that of Dop-ABI in
nondiabeticaswellasindiabeticpatients,
as validated against ultrasound. Further-
more, we deﬁned threshold values for
Osc-ABI measurement as a screening or
diagnostictestforPADinnondiabeticand
diabetic patients.
Our study showed that Dop-ABI and
Osc-ABIweresigniﬁcantlyrelated,aspre-
viously reported in several studies
(11,12,16).Bothmethodswerelimitedin
some patients (0.6% of the legs in our
population) when lower limb arteries
were not compressible. We also de-
scribed, for the ﬁrst time, evaluation of
the use of the oscillometric method in di-
abetic patients. Indeed, we showed that
Osc-ABI was obtained in most diabetic
patients and related to Dop-ABI. Further-
more, the low rate of failure for Osc-ABI
(1.3% of diabetic patients) showed that
most arteries could be evaluated with this
method. The availability of an automated
oscillometric method in diabetic subjects
isofparticularinterestbecausePADisfre-
quently associated with few clinical
symptoms (10). Indeed, we validated
both Dop-ABI and Osc-ABI against ultra-
sound as a reference and Osc-ABI against
Dop-ABI as a reference in diabetic pa-
tientsandestablishedthresholdvaluesfor
detection of artery stenosis. The analysis
of ROC curves showed that Dop-ABI was
slightly better than Osc-ABI in diabetic
patients. Despite this difference, Osc-ABI
could represent an alternative method for
ABI measurement, even in diabetic pa-
tients, with the beneﬁt that this method is
more readily available than Doppler
measurement.
Our study further extended the eval-
uation of Dop-ABI and Osc-ABI as a diag-
nostic or a screening test. Setting the
threshold at 0.90 led to a PPV 95% and
a threshold of 1.1 led to an NPV 99%
(17–19).Inourstudy,Dop-ABIshoweda
similar PPV (95%) at a threshold of 0.90
but a lower NPV (76%) with a threshold
of 1.1. This result may be related to dif-
ferences in the populations studied: the
relatively smaller size of our population
and higher-risk patients. We demon-
strated similar results with Osc-ABI and
Dop-ABI in the same patients, with PPV
and NPV that were 10% lower in the dia-
betic subpopulation. Despite this differ-
ence, the diagnostic accuracy of Osc-ABI
remained high enough to conclude that it
could help in PAD assessment in diabetic
patients. Indeed, PAD is frequent in dia-
betic patients, despite missing or con-
founding clinical symptoms, because of
its coexistence with neuropathy (10).
Thus, the use of Osc-ABI as a routine test
could improve PAD diagnosis and man-
agement of lower limb complications in
diabetes (8).
Further,weestablishedthresholdval-
ues of ABI optimized for a screening pur-
pose. The ROC curves showed that both
Dop-ABI and Osc-ABI could be used for
screeningforarterialstenosiswithacutoff
set at 1.0 to 1.1, which identiﬁed 80%
of the patients with PAD whatever the
technique used and the presence or ab-
sence of diabetes. These results were in
agreement with those reported for Dop-
ABI with a normal value between 1 and
1.2 (2,5,17,20).
Obstacles to adopting ABI measure-
ment for PAD diagnosis in primary care
were identiﬁed previously as time, cost,
and the need for a dedicated device and
operator skill (6,7,12). In contrast, we
have demonstrated that Osc-ABI can be
easily performed by clinical assistants,
i.e., nurses or others, after minimal train-
ing and with commonly available devices
(2,7). The 1 to 1.1 threshold value would
identify most patients with PAD. This ap-
proach represents substantial savings of
costs and time, with a signiﬁcant im-
provement in the diagnosis and manage-
ment of PAD in the general population
and particularly in diabetic patients. Our
study was not designed for cost-effective-
ness evaluation; however, we showed that
theuseofOsc-ABI,asﬁrst-linescreeningfor
PAD, would reduce by 61 and 75% the use
of vascular studies for PAD diagnosis (25 of
Figure 2—ROC Curves for Osc-ABI for diagnosis of PAD, as deﬁned with Dop-ABI 0.90 in the whole population (A), diabetic patients (B), and
nondiabetic patients (C). D: Best cutoff determination for maximizing both the sensitivity and the speciﬁcity in the whole population, diabetic and
nondiabetic patients. ——, sensitivity;––– ,speciﬁcity.
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in nondiabetic and diabetic patients
Threshold value ABI
Sensitivity (%) Speciﬁcity (%) NPV (%) NLR PPV (%) PLR
Dop Osc Dop Osc Dop Osc Dop Osc Dop Osc Dop Osc
Total population
0.90 63.1 39.7 97.5 95.6 76.1 65.9 0.38 0.63 95.3 88.1 24.3 9.0
1 73.1 58.8 94.9 88.7 81.0 72.4 0.28 0.46 92.2 81.0 14.3 5.2
1.1 87.7 81.7 59.8 68.1 85.5 82.0 0.2 0.27 64.4 67.7 2.19 2.6
No diabetes
0.90 72.6 50.7 98.3 95.0 77.6 65.5 0.47 0.71 97.8 91.6 42.7 10.5
1 80.6 69.8 91.6 88.3 82.1 73.6 0.35 0.57 90.9 86.2 9.7 6.0
1.1 93.5 90.5 46.6 63.3 87.5 86.3 0.26 0.37 64.4 72.1 1.75 2.5
Diabetes
0.90 54.4 29.4 96.8 95.9 74.7 66.2 0.28 0.50 92.5 83.3 17.0 7.9
1 66.2 48.5 96.8 90.8 80 71.8 0.21 0.34 93.7 78.6 20.7 5.3
1.1 82.4 73.5 68.4 72.4 84.4 79.8 0.14 0.15 65.1 64.9 2.60 2.7
NLR, negative likelihood ratio; PLR, positive likelihood ratio.
Figure 3—ROC curves for Dop-ABI and Osc-ABI for diagnosis of ultrasound-identiﬁed arterial stenosis in the whole population (A), diabetic
patients (B), and nondiabetic patients (C). Black square, Osc-ABI; gray diamond, Dop-ABI. D: Osc-ABI. E: Dop-ABI best cutoff determination for
maximizing both the sensitivity and the speciﬁcity in the whole population, diabetic and nondiabetic patients. ——, sensitivity;––– ,speciﬁcity.
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betic patients). In patients in whom distal
artery pulses were not palpable, vascular
studieswouldhavebeenreducedby24and
36% in nondiabetic and diabetic patients,
respectively. The reduction of costs
(roughly divided by a factor of 3) clearly
supports the hypothesis of cost saving in
PAD diagnosis with the use of Osc-ABI, as
measuredbynursesandclinicalstaff.More-
over, the early recognition of PAD would
improve the management of lower limb
complications and cardiovascular risk fac-
tors in the general population, with a fur-
ther reduction in costs because of early
intervention for modiﬁable cardiovascular
risk factors (10,21). Nevertheless, the cost-
effectiveness of Osc-ABI needs to be as-
sessed in a study speciﬁcally design for that
purpose.
In summary, our study showed that
Osc-ABI measurement was feasible for
clinical assistants using an automatic
blood pressure monitoring device. This
maybealow-costandeffectiveprocedure
to improve PAD management in at-risk
patients,includingsubjectswithdiabetes,
with early recognition and appropriate
counseling for the control of modiﬁable
cardiovascular risk factors.
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